1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Kidney/Renal Fibrosis Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Angiotensin II Receptor Blockers (ARBs) 1.2.3 Angiotensin Converting Enzyme (ACE) Inhibitors 1.2.4 Pirfenidone 1.2.5 Renin Inhibitors 1.2.6 Vasopeptidase Inhibitors 1.3 Market by Application 1.3.1 Global Kidney/Renal Fibrosis Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Commercial/Private Hospitals 1.3.3 Public Health Hospitals 1.3.4 Clinics 1.3.5 Home Treatment 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Kidney/Renal Fibrosis Treatment Market Perspective (2017-2028) 2.2 Kidney/Renal Fibrosis Treatment Growth Trends by Region 2.2.1 Kidney/Renal Fibrosis Treatment Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Kidney/Renal Fibrosis Treatment Historic Market Size by Region (2017-2022) 2.2.3 Kidney/Renal Fibrosis Treatment Forecasted Market Size by Region (2023-2028) 2.3 Kidney/Renal Fibrosis Treatment Market Dynamics 2.3.1 Kidney/Renal Fibrosis Treatment Industry Trends 2.3.2 Kidney/Renal Fibrosis Treatment Market Drivers 2.3.3 Kidney/Renal Fibrosis Treatment Market Challenges 2.3.4 Kidney/Renal Fibrosis Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Kidney/Renal Fibrosis Treatment Players by Revenue 3.1.1 Global Top Kidney/Renal Fibrosis Treatment Players by Revenue (2017-2022) 3.1.2 Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Players (2017-2022) 3.2 Global Kidney/Renal Fibrosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Kidney/Renal Fibrosis Treatment Revenue 3.4 Global Kidney/Renal Fibrosis Treatment Market Concentration Ratio 3.4.1 Global Kidney/Renal Fibrosis Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Kidney/Renal Fibrosis Treatment Revenue in 2021 3.5 Kidney/Renal Fibrosis Treatment Key Players Head office and Area Served 3.6 Key Players Kidney/Renal Fibrosis Treatment Product Solution and Service 3.7 Date of Enter into Kidney/Renal Fibrosis Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Kidney/Renal Fibrosis Treatment Breakdown Data by Type 4.1 Global Kidney/Renal Fibrosis Treatment Historic Market Size by Type (2017-2022) 4.2 Global Kidney/Renal Fibrosis Treatment Forecasted Market Size by Type (2023-2028) 5 Kidney/Renal Fibrosis Treatment Breakdown Data by Application 5.1 Global Kidney/Renal Fibrosis Treatment Historic Market Size by Application (2017-2022) 5.2 Global Kidney/Renal Fibrosis Treatment Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Kidney/Renal Fibrosis Treatment Market Size (2017-2028) 6.2 North America Kidney/Renal Fibrosis Treatment Market Size by Type 6.2.1 North America Kidney/Renal Fibrosis Treatment Market Size by Type (2017-2022) 6.2.2 North America Kidney/Renal Fibrosis Treatment Market Size by Type (2023-2028) 6.2.3 North America Kidney/Renal Fibrosis Treatment Market Share by Type (2017-2028) 6.3 North America Kidney/Renal Fibrosis Treatment Market Size by Application 6.3.1 North America Kidney/Renal Fibrosis Treatment Market Size by Application (2017-2022) 6.3.2 North America Kidney/Renal Fibrosis Treatment Market Size by Application (2023-2028) 6.3.3 North America Kidney/Renal Fibrosis Treatment Market Share by Application (2017-2028) 6.4 North America Kidney/Renal Fibrosis Treatment Market Size by Country 6.4.1 North America Kidney/Renal Fibrosis Treatment Market Size by Country (2017-2022) 6.4.2 North America Kidney/Renal Fibrosis Treatment Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Kidney/Renal Fibrosis Treatment Market Size (2017-2028) 7.2 Europe Kidney/Renal Fibrosis Treatment Market Size by Type 7.2.1 Europe Kidney/Renal Fibrosis Treatment Market Size by Type (2017-2022) 7.2.2 Europe Kidney/Renal Fibrosis Treatment Market Size by Type (2023-2028) 7.2.3 Europe Kidney/Renal Fibrosis Treatment Market Share by Type (2017-2028) 7.3 Europe Kidney/Renal Fibrosis Treatment Market Size by Application 7.3.1 Europe Kidney/Renal Fibrosis Treatment Market Size by Application (2017-2022) 7.3.2 Europe Kidney/Renal Fibrosis Treatment Market Size by Application (2023-2028) 7.3.3 Europe Kidney/Renal Fibrosis Treatment Market Share by Application (2017-2028) 7.4 Europe Kidney/Renal Fibrosis Treatment Market Size by Country 7.4.1 Europe Kidney/Renal Fibrosis Treatment Market Size by Country (2017-2022) 7.4.2 Europe Kidney/Renal Fibrosis Treatment Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size (2017-2028) 8.2 Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size by Type 8.2.1 Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Kidney/Renal Fibrosis Treatment Market Share by Type (2017-2028) 8.3 Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size by Application 8.3.1 Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Kidney/Renal Fibrosis Treatment Market Share by Application (2017-2028) 8.4 Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size by Region 8.4.1 Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Kidney/Renal Fibrosis Treatment Market Size (2017-2028) 9.2 Latin America Kidney/Renal Fibrosis Treatment Market Size by Type 9.2.1 Latin America Kidney/Renal Fibrosis Treatment Market Size by Type (2017-2022) 9.2.2 Latin America Kidney/Renal Fibrosis Treatment Market Size by Type (2023-2028) 9.2.3 Latin America Kidney/Renal Fibrosis Treatment Market Share by Type (2017-2028) 9.3 Latin America Kidney/Renal Fibrosis Treatment Market Size by Application 9.3.1 Latin America Kidney/Renal Fibrosis Treatment Market Size by Application (2017-2022) 9.3.2 Latin America Kidney/Renal Fibrosis Treatment Market Size by Application (2023-2028) 9.3.3 Latin America Kidney/Renal Fibrosis Treatment Market Share by Application (2017-2028) 9.4 Latin America Kidney/Renal Fibrosis Treatment Market Size by Country 9.4.1 Latin America Kidney/Renal Fibrosis Treatment Market Size by Country (2017-2022) 9.4.2 Latin America Kidney/Renal Fibrosis Treatment Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size (2017-2028) 10.2 Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size by Type 10.2.1 Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Kidney/Renal Fibrosis Treatment Market Share by Type (2017-2028) 10.3 Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size by Application 10.3.1 Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Kidney/Renal Fibrosis Treatment Market Share by Application (2017-2028) 10.4 Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size by Country 10.4.1 Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Galectin Therapeutics 11.1.1 Galectin Therapeutics Company Details 11.1.2 Galectin Therapeutics Business Overview 11.1.3 Galectin Therapeutics Kidney/Renal Fibrosis Treatment Introduction 11.1.4 Galectin Therapeutics Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) 11.1.5 Galectin Therapeutics Recent Developments 11.2 Merck & Co. 11.2.1 Merck & Co. Company Details 11.2.2 Merck & Co. Business Overview 11.2.3 Merck & Co. Kidney/Renal Fibrosis Treatment Introduction 11.2.4 Merck & Co. Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) 11.2.5 Merck & Co. Recent Developments 11.3 F. Hoffman-La Roche Ltd. 11.3.1 F. Hoffman-La Roche Ltd. Company Details 11.3.2 F. Hoffman-La Roche Ltd. Business Overview 11.3.3 F. Hoffman-La Roche Ltd. Kidney/Renal Fibrosis Treatment Introduction 11.3.4 F. Hoffman-La Roche Ltd. Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) 11.3.5 F. Hoffman-La Roche Ltd. Recent Developments 11.4 Pfizer Inc. 11.4.1 Pfizer Inc. Company Details 11.4.2 Pfizer Inc. Business Overview 11.4.3 Pfizer Inc. Kidney/Renal Fibrosis Treatment Introduction 11.4.4 Pfizer Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) 11.4.5 Pfizer Inc. Recent Developments 11.5 InterMune Inc. 11.5.1 InterMune Inc. Company Details 11.5.2 InterMune Inc. Business Overview 11.5.3 InterMune Inc. Kidney/Renal Fibrosis Treatment Introduction 11.5.4 InterMune Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) 11.5.5 InterMune Inc. Recent Developments 11.6 ProMetic Life-Sciences Inc. 11.6.1 ProMetic Life-Sciences Inc. Company Details 11.6.2 ProMetic Life-Sciences Inc. Business Overview 11.6.3 ProMetic Life-Sciences Inc. Kidney/Renal Fibrosis Treatment Introduction 11.6.4 ProMetic Life-Sciences Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) 11.6.5 ProMetic Life-Sciences Inc. Recent Developments 11.7 La Jolla Pharmaceutical Company 11.7.1 La Jolla Pharmaceutical Company Company Details 11.7.2 La Jolla Pharmaceutical Company Business Overview 11.7.3 La Jolla Pharmaceutical Company Kidney/Renal Fibrosis Treatment Introduction 11.7.4 La Jolla Pharmaceutical Company Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) 11.7.5 La Jolla Pharmaceutical Company Recent Developments 11.8 Genzyme Corporation 11.8.1 Genzyme Corporation Company Details 11.8.2 Genzyme Corporation Business Overview 11.8.3 Genzyme Corporation Kidney/Renal Fibrosis Treatment Introduction 11.8.4 Genzyme Corporation Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) 11.8.5 Genzyme Corporation Recent Developments 11.9 BioLine Rx Ltd 11.9.1 BioLine Rx Ltd Company Details 11.9.2 BioLine Rx Ltd Business Overview 11.9.3 BioLine Rx Ltd Kidney/Renal Fibrosis Treatment Introduction 11.9.4 BioLine Rx Ltd Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) 11.9.5 BioLine Rx Ltd Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer

List of Tables Table 1. Global Kidney/Renal Fibrosis Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Angiotensin II Receptor Blockers (ARBs) Table 3. Key Players of Angiotensin Converting Enzyme (ACE) Inhibitors Table 4. Key Players of Pirfenidone Table 5. Key Players of Renin Inhibitors Table 6. Key Players of Vasopeptidase Inhibitors Table 7. Global Kidney/Renal Fibrosis Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 8. Global Kidney/Renal Fibrosis Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 9. Global Kidney/Renal Fibrosis Treatment Market Size by Region (2017-2022) & (US$ Million) Table 10. Global Kidney/Renal Fibrosis Treatment Market Share by Region (2017-2022) Table 11. Global Kidney/Renal Fibrosis Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 12. Global Kidney/Renal Fibrosis Treatment Market Share by Region (2023-2028) Table 13. Kidney/Renal Fibrosis Treatment Market Trends Table 14. Kidney/Renal Fibrosis Treatment Market Drivers Table 15. Kidney/Renal Fibrosis Treatment Market Challenges Table 16. Kidney/Renal Fibrosis Treatment Market Restraints Table 17. Global Kidney/Renal Fibrosis Treatment Revenue by Players (2017-2022) & (US$ Million) Table 18. Global Kidney/Renal Fibrosis Treatment Revenue Share by Players (2017-2022) Table 19. Global Top Kidney/Renal Fibrosis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney/Renal Fibrosis Treatment as of 2021) Table 20. Ranking of Global Top Kidney/Renal Fibrosis Treatment Companies by Revenue (US$ Million) in 2021 Table 21. Global 5 Largest Players Market Share by Kidney/Renal Fibrosis Treatment Revenue (CR5 and HHI) & (2017-2022) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Kidney/Renal Fibrosis Treatment Product Solution and Service Table 24. Date of Enter into Kidney/Renal Fibrosis Treatment Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Kidney/Renal Fibrosis Treatment Market Size by Type (2017-2022) & (US$ Million) Table 27. Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Type (2017-2022) Table 28. Global Kidney/Renal Fibrosis Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 29. Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Type (2023-2028) Table 30. Global Kidney/Renal Fibrosis Treatment Market Size by Application (2017-2022) & (US$ Million) Table 31. Global Kidney/Renal Fibrosis Treatment Revenue Share by Application (2017-2022) Table 32. Global Kidney/Renal Fibrosis Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 33. Global Kidney/Renal Fibrosis Treatment Revenue Share by Application (2023-2028) Table 34. North America Kidney/Renal Fibrosis Treatment Market Size by Type (2017-2022) & (US$ Million) Table 35. North America Kidney/Renal Fibrosis Treatment Market Size by Type (2023-2028) & (US$ Million) Table 36. North America Kidney/Renal Fibrosis Treatment Market Size by Application (2017-2022) & (US$ Million) Table 37. North America Kidney/Renal Fibrosis Treatment Market Size by Application (2023-2028) & (US$ Million) Table 38. North America Kidney/Renal Fibrosis Treatment Market Size by Country (2017-2022) & (US$ Million) Table 39. North America Kidney/Renal Fibrosis Treatment Market Size by Country (2023-2028) & (US$ Million) Table 40. Europe Kidney/Renal Fibrosis Treatment Market Size by Type (2017-2022) & (US$ Million) Table 41. Europe Kidney/Renal Fibrosis Treatment Market Size by Type (2023-2028) & (US$ Million) Table 42. Europe Kidney/Renal Fibrosis Treatment Market Size by Application (2017-2022) & (US$ Million) Table 43. Europe Kidney/Renal Fibrosis Treatment Market Size by Application (2023-2028) & (US$ Million) Table 44. Europe Kidney/Renal Fibrosis Treatment Market Size by Country (2017-2022) & (US$ Million) Table 45. Europe Kidney/Renal Fibrosis Treatment Market Size by Country (2023-2028) & (US$ Million) Table 46. Asia Pacific Kidney/Renal Fibrosis Treatment Market Size by Type (2017-2022) & (US$ Million) Table 47. Asia Pacific Kidney/Renal Fibrosis Treatment Market Size by Type (2023-2028) & (US$ Million) Table 48. Asia Pacific Kidney/Renal Fibrosis Treatment Market Size by Application (2017-2022) & (US$ Million) Table 49. Asia Pacific Kidney/Renal Fibrosis Treatment Market Size by Application (2023-2028) & (US$ Million) Table 50. Asia Pacific Kidney/Renal Fibrosis Treatment Market Size by Region (2017-2022) & (US$ Million) Table 51. Asia Pacific Kidney/Renal Fibrosis Treatment Market Size by Region (2023-2028) & (US$ Million) Table 52. Latin America Kidney/Renal Fibrosis Treatment Market Size by Type (2017-2022) & (US$ Million) Table 53. Latin America Kidney/Renal Fibrosis Treatment Market Size by Type (2023-2028) & (US$ Million) Table 54. Latin America Kidney/Renal Fibrosis Treatment Market Size by Application (2017-2022) & (US$ Million) Table 55. Latin America Kidney/Renal Fibrosis Treatment Market Size by Application (2023-2028) & (US$ Million) Table 56. Latin America Kidney/Renal Fibrosis Treatment Market Size by Country (2017-2022) & (US$ Million) Table 57. Latin America Kidney/Renal Fibrosis Treatment Market Size by Country (2023-2028) & (US$ Million) Table 58. Middle East and Africa Kidney/Renal Fibrosis Treatment Market Size by Type (2017-2022) & (US$ Million) Table 59. Middle East and Africa Kidney/Renal Fibrosis Treatment Market Size by Type (2023-2028) & (US$ Million) Table 60. Middle East and Africa Kidney/Renal Fibrosis Treatment Market Size by Application (2017-2022) & (US$ Million) Table 61. Middle East and Africa Kidney/Renal Fibrosis Treatment Market Size by Application (2023-2028) & (US$ Million) Table 62. Middle East and Africa Kidney/Renal Fibrosis Treatment Market Size by Country (2017-2022) & (US$ Million) Table 63. Middle East and Africa Kidney/Renal Fibrosis Treatment Market Size by Country (2023-2028) & (US$ Million) Table 64. Galectin Therapeutics Company Details Table 65. Galectin Therapeutics Business Overview Table 66. Galectin Therapeutics Kidney/Renal Fibrosis Treatment Product Table 67. Galectin Therapeutics Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) & (US$ Million) Table 68. Galectin Therapeutics Recent Developments Table 69. Merck & Co. Company Details Table 70. Merck & Co. Business Overview Table 71. Merck & Co. Kidney/Renal Fibrosis Treatment Product Table 72. Merck & Co. Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) & (US$ Million) Table 73. Merck & Co. Recent Developments Table 74. F. Hoffman-La Roche Ltd. Company Details Table 75. F. Hoffman-La Roche Ltd. Business Overview Table 76. F. Hoffman-La Roche Ltd. Kidney/Renal Fibrosis Treatment Product Table 77. F. Hoffman-La Roche Ltd. Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) & (US$ Million) Table 78. F. Hoffman-La Roche Ltd. Recent Developments Table 79. Pfizer Inc. Company Details Table 80. Pfizer Inc. Business Overview Table 81. Pfizer Inc. Kidney/Renal Fibrosis Treatment Product Table 82. Pfizer Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) & (US$ Million) Table 83. Pfizer Inc. Recent Developments Table 84. InterMune Inc. Company Details Table 85. InterMune Inc. Business Overview Table 86. InterMune Inc. Kidney/Renal Fibrosis Treatment Product Table 87. InterMune Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) & (US$ Million) Table 88. InterMune Inc. Recent Developments Table 89. ProMetic Life-Sciences Inc. Company Details Table 90. ProMetic Life-Sciences Inc. Business Overview Table 91. ProMetic Life-Sciences Inc. Kidney/Renal Fibrosis Treatment Product Table 92. ProMetic Life-Sciences Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) & (US$ Million) Table 93. ProMetic Life-Sciences Inc. Recent Developments Table 94. La Jolla Pharmaceutical Company Company Details Table 95. La Jolla Pharmaceutical Company Business Overview Table 96. La Jolla Pharmaceutical Company Kidney/Renal Fibrosis Treatment Product Table 97. La Jolla Pharmaceutical Company Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) & (US$ Million) Table 98. La Jolla Pharmaceutical Company Recent Developments Table 99. Genzyme Corporation Company Details Table 100. Genzyme Corporation Business Overview Table 101. Genzyme Corporation Kidney/Renal Fibrosis Treatment Product Table 102. Genzyme Corporation Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) & (US$ Million) Table 103. Genzyme Corporation Recent Developments Table 104. BioLine Rx Ltd Company Details Table 105. BioLine Rx Ltd Business Overview Table 106. BioLine Rx Ltd Kidney/Renal Fibrosis Treatment Product Table 107. BioLine Rx Ltd Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) & (US$ Million) Table 108. BioLine Rx Ltd Recent Developments Table 109. Research Programs/Design for This Report Table 110. Key Data Information from Secondary Sources Table 111. Key Data Information from Primary Sources List of Figures Figure 1. Global Kidney/Renal Fibrosis Treatment Market Share by Type: 2021 VS 2028 Figure 2. Angiotensin II Receptor Blockers (ARBs) Features Figure 3. Angiotensin Converting Enzyme (ACE) Inhibitors Features Figure 4. Pirfenidone Features Figure 5. Renin Inhibitors Features Figure 6. Vasopeptidase Inhibitors Features Figure 7. Global Kidney/Renal Fibrosis Treatment Market Share by Application: 2021 VS 2028 Figure 8. Commercial/Private Hospitals Case Studies Figure 9. Public Health Hospitals Case Studies Figure 10. Clinics Case Studies Figure 11. Home Treatment Case Studies Figure 12. Kidney/Renal Fibrosis Treatment Report Years Considered Figure 13. Global Kidney/Renal Fibrosis Treatment Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 14. Global Kidney/Renal Fibrosis Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 15. Global Kidney/Renal Fibrosis Treatment Market Share by Region: 2021 VS 2028 Figure 16. Global Kidney/Renal Fibrosis Treatment Market Share by Players in 2021 Figure 17. Global Top Kidney/Renal Fibrosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney/Renal Fibrosis Treatment as of 2021) Figure 18. The Top 10 and 5 Players Market Share by Kidney/Renal Fibrosis Treatment Revenue in 2021 Figure 19. North America Kidney/Renal Fibrosis Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 20. North America Kidney/Renal Fibrosis Treatment Market Size Market Share by Type (2017-2028) Figure 21. North America Kidney/Renal Fibrosis Treatment Market Size Market Share by Application (2017-2028) Figure 22. North America Kidney/Renal Fibrosis Treatment Market Size Share by Country (2017-2028) Figure 23. United States Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Canada Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Europe Kidney/Renal Fibrosis Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 26. Europe Kidney/Renal Fibrosis Treatment Market Size Market Share by Type (2017-2028) Figure 27. Europe Kidney/Renal Fibrosis Treatment Market Size Market Share by Application (2017-2028) Figure 28. Europe Kidney/Renal Fibrosis Treatment Market Size Share by Country (2017-2028) Figure 29. Germany Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. France Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. U.K. Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Italy Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Russia Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Nordic Countries Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 36. Asia Pacific Kidney/Renal Fibrosis Treatment Market Size Market Share by Type (2017-2028) Figure 37. Asia Pacific Kidney/Renal Fibrosis Treatment Market Size Market Share by Application (2017-2028) Figure 38. Asia Pacific Kidney/Renal Fibrosis Treatment Market Size Share by Region (2017-2028) Figure 39. China Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Japan Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. South Korea Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Southeast Asia Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. India Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Australia Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 45. Latin America Kidney/Renal Fibrosis Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 46. Latin America Kidney/Renal Fibrosis Treatment Market Size Market Share by Type (2017-2028) Figure 47. Latin America Kidney/Renal Fibrosis Treatment Market Size Market Share by Application (2017-2028) Figure 48. Latin America Kidney/Renal Fibrosis Treatment Market Size Share by Country (2017-2028) Figure 49. Mexico Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 50. Brazil Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 51. Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 52. Middle East and Africa Kidney/Renal Fibrosis Treatment Market Size Market Share by Type (2017-2028) Figure 53. Middle East and Africa Kidney/Renal Fibrosis Treatment Market Size Market Share by Application (2017-2028) Figure 54. Middle East and Africa Kidney/Renal Fibrosis Treatment Market Size Share by Country (2017-2028) Figure 55. Turkey Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 56. Saudi Arabia Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 57. UAE Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 58. Galectin Therapeutics Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2017-2022) Figure 59. Merck & Co. Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2017-2022) Figure 60. F. Hoffman-La Roche Ltd. Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2017-2022) Figure 61. Pfizer Inc. Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2017-2022) Figure 62. InterMune Inc. Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2017-2022) Figure 63. ProMetic Life-Sciences Inc. Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2017-2022) Figure 64. La Jolla Pharmaceutical Company Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2017-2022) Figure 65. Genzyme Corporation Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2017-2022) Figure 66. BioLine Rx Ltd Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2017-2022) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed

Galectin Therapeutics Merck & Co. F. Hoffman-La Roche Ltd. Pfizer Inc. InterMune Inc. ProMetic Life-Sciences Inc. La Jolla Pharmaceutical Company Genzyme Corporation BioLine Rx Ltd